Cargando…
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
LGD-4033 (ligandrol) is a selective androgen receptor modulator (SARM), which is prohibited in sports by the World Anti-Doping Agency (WADA) and led to 62 adverse analytical findings (AAFs) in 2019. But not only deliberate doping with LGD-4033 constitutes a problem. In the past years, some AAFs that...
Autores principales: | Wagener, Felicitas, Guddat, Sven, Görgens, Christian, Angelis, Yiannis S., Petrou, Michael, Lagojda, Andreas, Kühne, Dirk, Thevis, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724150/ https://www.ncbi.nlm.nih.gov/pubmed/34734312 http://dx.doi.org/10.1007/s00216-021-03740-7 |
Ejemplares similares
-
Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes
por: Wagener, Felicitas, et al.
Publicado: (2022) -
Ligandrol (LGD-4033)-Induced Liver Injury
por: Barbara, Mary, et al.
Publicado: (2020) -
Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry
por: Breuer, Johanna, et al.
Publicado: (2022) -
Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics
por: Kwiatkowska, Dorota, et al.
Publicado: (2023) -
Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140
por: Wagener, Felicitas, et al.
Publicado: (2023)